Ram F S F, Ducharme F M, Scarlett J
Massey University - Albany, School of Health Sciences, Private Bag 102 904, North Shore Mail Centre, Auckland, New Zealand.
Cochrane Database Syst Rev. 2007 Jul 18;2007(2):CD003795. doi: 10.1002/14651858.CD003795.pub2.
In infants with a family history of atopy, food allergen avoidance has been advocated as means of preventing the development of atopic disease, when breast-feeding is not possible or supplemental feeding is needed. Most infant formulas are based on cow's milk protein. Alternative choices include soya based and hydrolysed cows milk formulas.
To estimate the effect of dietary avoidance of cow's milk protein on the development of asthma or wheeze in children.
We searched the Cochrane database for eligible trials until February 2002. We obtained the full text papers of all abstracts identified as RCTs and two reviewers independently reviewed them.
We included randomised controlled trials involving children with a family history of atopy in at least one first degree relative, if feeding with cow's milk based standard formula was compared to dietary avoidance of cow's milk protein, using soya or other hypoallergenic formula during the initial four months of life or longer.
Two reviewers extracted data independently. A priori defined subgroups were the types of hypoallergenic artificial feed and dietary restrictions on mother and/or child's diet.
Six trials used hydrolysed formula for at least four months, in addition to dietary restrictions and in some cases dust-mite reduction measures. The risk of infants experiencing asthma or wheeze during the first year of life was reduced compared to standard cow's milk based formula (Relative Risk 0.40, 95% Confidence Intervals 0.19 to 0.85). Feeding soya-based formula as opposed to standard cow's milk formula did not reduce the risk of having asthma or wheeze at any age.
AUTHORS' CONCLUSIONS: Breast-milk should remain the feed of choice for all babies. In infants with at least one first degree relative with atopy, hydrolysed formula for a minimum of four months combined with dietary restrictions and environment measures may reduce the risk of developing asthma or wheeze in the first year of life. There is insufficient evidence to suggest that soya-based milk formula has any benefit.
对于有特应性家族史的婴儿,在无法进行母乳喂养或需要补充喂养时,提倡避免食用食物过敏原,以此作为预防特应性疾病发展的手段。大多数婴儿配方奶粉以牛奶蛋白为基础。其他选择包括大豆基配方奶粉和水解牛奶配方奶粉。
评估饮食中避免牛奶蛋白对儿童哮喘或喘息发展的影响。
我们检索了Cochrane数据库,以查找截至2002年2月的符合条件的试验。我们获取了所有被确定为随机对照试验的摘要的全文论文,两名评审员独立对其进行了评审。
我们纳入了涉及至少有一位一级亲属有特应性家族史的儿童的随机对照试验,如果将以牛奶为基础的标准配方奶粉喂养与在生命最初四个月或更长时间内饮食中避免牛奶蛋白、使用大豆或其他低敏配方奶粉进行比较。
两名评审员独立提取数据。预先定义的亚组为低敏人工喂养的类型以及对母亲和/或儿童饮食的饮食限制。
六项试验使用水解配方奶粉至少四个月,同时进行饮食限制,在某些情况下还采取了减少尘螨措施。与基于标准牛奶的配方奶粉相比,婴儿在生命第一年出现哮喘或喘息的风险降低(相对风险0.40,95%置信区间0.19至0.85)。与标准牛奶配方奶粉相比,喂养大豆基配方奶粉在任何年龄都不会降低患哮喘或喘息的风险。
母乳应始终是所有婴儿的首选喂养方式。对于至少有一位一级亲属有特应性的婴儿,至少四个月的水解配方奶粉与饮食限制和环境措施相结合,可能会降低生命第一年患哮喘或喘息的风险。没有足够的证据表明大豆基牛奶配方奶粉有任何益处。